ArticleLancet (London, England)2022
Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Article in Lancet (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
93 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Unmet need for family planning among reproductive-age women living with HIV in Africa: a systematic review and meta-analysis.BMC women's health · 2026Pooled it
- Beyond individual-level factors that influence family planning uptake among women with diabetes mellitus: a systematic literature review.BMC public health · 2025Pooled it
- Post-abortion contraceptive uptake, choices, and factors associated with it among women seeking abortion services in Africa: a systematic review and meta-analysis.Frontiers in global women's health · 2025Pooled it
- Youth-Friendly Sexual Health Services and Peer Support for Improved Sexual and Reproductive Health Outcomes Among Adolescents and Young Adults in South Africa: Results of a Factorial Randomized Controlled Trial.Sexually transmitted diseases · 2025Trial
- Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084.Journal of the International AIDS Society · 2025Trial
- Trial
- 50 years of contraception: trends in contraception prevalence rate and unmet family planning needs in twenty Arab countries (1970-2020).BMJ global health · 2026Article
- Article
- Determinants of family planning use among married women of reproductive age in south Asia: a systematic review and meta-analysis.The Lancet regional health. Southeast Asia · 2026Article
- Preferences for characteristics of contraceptive methods: a large, multi-country discrete choice experiment.BMJ global health · 2026Article
- Cervical cancer burden and elimination readiness in the US-affiliated Pacific Islands: A structured narrative review.Cancer epidemiology · 2026Review
- Oral contraceptive usage among healthcare workers and its impact on COVID-19 booster vaccination immunogenicity.NPJ vaccines · 2026Article
- Article
- Safety and effectiveness of etonogestrel implant in Chinese women requiring contraception: a multicenter, prospective, observational study.Archives of gynecology and obstetrics · 2026Observational
- Modern contraceptive discontinuation and demand-and-supply-side method-mix in urban settings in Eastern Uganda: a mixed methods study.Contraception and reproductive medicine · 2026Article
- Leveraging connections between family planning and nutrition to improve the health of women.BMJ global health · 2026Review
- Cost-effectiveness of four contraceptive methods to avoid unintended pregnancy among adolescents in China: an analysis based on decision-tree model.Contraception and reproductive medicine · 2026Article
- Reproductive health awareness in Romania: women's knowledge, practices, and information-seeking behaviors.Contraception and reproductive medicine · 2026Article
- Comparison of tubal reanastomosis and in vitro fertilisation for restoring fertility in women with a history of tubal ligation.BMC pregnancy and childbirth · 2026Article
- The Effect of TISSEELMedicina (Kaunas, Lithuania) · 2026Article
33 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMeeting the contraceptive needs of women of reproductive age is beneficial for the health of women and children, and the economic and social empowerment of women. Higher rates of contraceptive coverage have been linked to the availability of a more diverse range of contraceptive methods. We present estimates of the contraceptive prevalence rate (CPR), modern contraceptive prevalence rate (mCPR), demand satisfied, and the method of contraception used for both partnered and unpartnered women for 5-year age groups in 204 countries and territories between 1970 and 2019.
methodsWe used 1162 population-based surveys capturing contraceptive use among women between 1970 and 2019, in which women of reproductive age (15-49 years) self-reported their, or their partner's, current use of contraception for family planning purposes. Spatiotemporal Gaussian process regression was used to generate estimates of the CPR, mCPR, demand satisfied, and method mix by age and marital status. We assessed how age-specific mCPR and demand satisfied changed with the Socio-demographic Index (SDI), a measure of social and economic development, using the meta-regression Bayesian, regularised, trimmed method from the Global Burden of Diseases, Injuries, and Risk Factors Study.
findingsIn 2019, 162·9 million (95% uncertainty interval [UI] 155·6-170·2) women had unmet need for contraception, of whom 29·3% (27·9-30·6) resided in sub-Saharan Africa and 27·2% (24·4-30·3) resided in south Asia. Women aged 15-19 years (64·8% [62·9-66·7]) and 20-24 years (71·9% [68·9-74·2]) had the lowest rates of demand satisfied, with 43·2 million (95% UI 39·3-48·0) women aged 15-24 years with unmet need in 2019. The mCPR and demand satisfied among women aged 15-19 years were substantially lower than among women aged 20-49 years at SDI values below 60 (on a 0-100 scale), but began to equalise as SDI increased above 60. Between 1970 and 2019, the global mCPR increased by 20·1 percentage points (95% UI 18·7-21·6). During this time, traditional methods declined as a proportion of all contraceptive methods, whereas the use of implants, injections, female sterilisation, and condoms increased. Method mix differs substantially depending on age and geography, with the share of female sterilisation increasing with age and comprising more than 50% of methods in use in south Asia. In 28 countries, one method was used by more than 50% of users in 2019.
interpretationThe dominance of one contraceptive method in some locations raises the question of whether family planning policies should aim to expand method mix or invest in making existing methods more accessible. Lower rates of demand satisfied among women aged 15-24 years are also concerning because unintended pregnancies before age 25 years can forestall or eliminate education and employment opportunities that lead to social and economic empowerment. Policy makers should strive to tailor family planning programmes to the preferences of the groups with the most need, while maintaining the programmes used by existing users.
fundingBill & Melinda Gates Foundation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.